Next Article in Journal
Characterization of Two Mitogenomes of Hyla sanchiangensis (Anura: Hylidae), with Phylogenetic Relationships and Selection Pressure Analyses of Hylidae
Previous Article in Journal
The Role of Veterinarians in Managing Community Cats: A Contextualized, Comprehensive Approach for Biodiversity, Public Health, and Animal Welfare
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Human-Animal Interaction in Animal-Assisted Interventions (AAI)s: Zoonosis Risks, Benefits, and Future Directions—A One Health Approach

by
Giovanna Liguori
1,2,†,
Anna Costagliola
1,*,†,
Renato Lombardi
2,
Orlando Paciello
1 and
Antonio Giordano
3,4
1
Department of Veterinary Medicine and Animal Productions, University of Napoli Federico II, 80138 Napoli, Italy
2
Local Health Authority, ASL Foggia, 71122 Foggia, Italy
3
Sbarro Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA
4
Department of Medical Biotechnology, University of Siena, 53100 Siena, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Animals 2023, 13(10), 1592; https://doi.org/10.3390/ani13101592
Submission received: 27 March 2023 / Revised: 1 May 2023 / Accepted: 8 May 2023 / Published: 9 May 2023
(This article belongs to the Section Human-Animal Interactions, Animal Behaviour and Emotion)

Abstract

:

Simple Summary

Animal-assisted interventions (AAI)s are planned activities carried out in multidisciplinary teams with educational, therapeutic, and ludic-recreational purposes. The multidisciplinary and integrated character identifies AAIs as the expression of one health. While AAIs offer many advantages to subjects, they could be exposed to several zoonotic-pathogens transmissions. Therefore, positive animal welfare, as preventive medicine to avoid accidents or zoonotic transmissions, is a relevant aspect with implications for human and animal health and welfare. The knowledge of several pathogens causing zoonoses in the animal species employed during the AAIs, as well as the preventive measures aimed at reducing and/or preventing the risk, guarantee their safety for patients. This review defines the future outcomes of the AAIs including the strengthening of preventive measures according to a “One Health approach”, the training of the personnel involved in AAIs, and the standardized protocols for hygiene–health–behavioral monitoring, aimed at a future production of health and behavioral certifications.

Abstract

Animal-assisted interventions (AAI)s represent the expression of integrated medicine, according to the One Health approach. Actually, animal-assisted therapies and animal-assisted activities are implemented in hospitals, rehabilitation centers, etc. The efficacy of AAIs is based on interspecific interactions and would be impacted by different factors, such as the characters of both the animal and the handler, a suitable selection of animal species, an appropriate animal educational protocol, the relationship between the handler and the animal, and mutual relationship among the animal, the patients, and members of the working team. AAIs produce many advantages for the patients but could expose them to zoonotic-pathogens transmission. Therefore, positive animal welfare, as preventative medicine to avoid incidents or transmission of zoonosis, is a relevant aspect with implications for human and animal health and wellbeing. This review aims to summarize the current published knowledge regarding the occurrence of pathogens in AAIs and to discuss their relevance in light of health and safety in AAIs participants. In addition, this review will contribute to defining the state of the art of AAIs through a careful benefits/challenges analysis and offers discussion points on the possible future developments according to the One Health approach.

1. Introduction

Animal-assisted interventions (AAI)s, generally defined as ‘pet therapy’, represent a wide variety of programmed activities involving animals finalized to the improvement of human health. AAIs are characterized by a multidisciplinary staff of human beings and animals with the purpose of striving for therapeutic (animal-assisted therapy—AAT) or educational (animal-assisted education—AAE) outcomes. In addition, AAIs involve animal-assisted activities (AAA) and AAI resident animals (RA) [1,2], as well as nonformal interventions performed on a voluntary basis by the multidisciplinary team with motivational, educational, or recreational goals [1]. AATs contribute to improving the health and welfare of the patients [3] and can play an adjuvant role during emotional–affective, social, linguistic, and cognitive rehabilitation [4,5,6,7]. Therefore, several scientific studies, mainly concerning dog-assisted therapy, led researchers to highlight the substantial beneficial effects induced in patients affected by depression/anxiety and/or psychophysical disorders, such as adults with autism spectrum [8], or Alzheimer’s diseases and other forms of dementia [6,9,10], or during psychotherapy sessions for adolescents [11], and in post-traumatic stress disorders in adults, adolescents, children, and soldiers [11,12,13,14].
The constraints of some pharmacological therapies against Alzheimer’s disease, autism spectrum disorder, and Parkinson’s disease, have conducted researchers to search for new therapeutic options, focusing on AATs. These are considered therapies to complement conventional ones [4,5,6,8,15,16]. However, the new frontier of integrated medicine focuses on the prevention and treatment of several diseases via a biopsychosocial multidisciplinary approach [17,18,19,20].
AAIs are now introduced in several different settings, including schools, nursing homes, hospitals, prisons, daycare centers, and social farms [21,22,23], even though more evidenced prominent research is still necessary [21,24]. The public great uproar recently encountered about the topic has ordered the sector to consider the role of animals in human health promotion, and focus on ethical [25], safety [21,26], and economic debates [21,27].
Thus, some international associations and organizations have elaborated standards and best practices for AAIs such as the White Paper of the International Association of Human-Animal Interaction Organizations [28], or the Animal-Assisted Interventions Code of Practice for the UK, edited by the Society for Companion Animal Studies [29]. Similar to other Western countries, in 2015, an agreement between the Italian Government, the regional authorities, and the autonomous provinces of Trento and Bolzano was established, setting up guidelines on AAIs [30] with the aim of guiding and improving the development of the AAI topic through a dialogue among the institutions, the stakeholders, and the scientific world.
Currently, all Italian regions are transposing and implementing the agreement. In the Italian Agreement, five animal species are cited: the dog (Canis familiaris), the cat (Felis catus), the rabbit (Oryctolagus cuniculus), the horse (Equus caballus), and the donkey (Equus asinus) [21].
Although most of the studies on AAI have focused on dog-assisted interventions, equine-assisted interventions (EAI) as an emerging field of AAI have been found to promote physical and mental health. In EAI, horses also cofacilitate therapeutic or recreative environments. EAI includes several activities like horseback riding, but also activities such as adapted acrobatics, carriage driving, grooming, and caring for and interacting with horses [31]. Since EAI seems to alleviate emotional, social, cognitive, and physical disorders in various healthcare settings, this procedure is currently used to treat neurological or psychiatric disorders [32,33,34] and other disabilities such as autism-spectrum disorder [35,36]. In addition, EAI positively affects people affected by Down’s syndrome [37] or poststroke subjects [38]. During EAI, the rider’s movements are rhythmic and regular [39]; therefore, patients affected by motor disabilities tend to adapt their locomotor system to the rhythmic movements of the horse to improve balance and coordination [40,41,42].
In addition to dogs, cats, rabbits, horses, and donkeys, which can be involved in AAT and AAE, there are other domestic animal species that are involved in AAA as well (guinea pigs, chickens, goats, ferrets, etc.), although they still need to be evaluated by national authorities as regards their safety and welfare before they can become suitable officially for AAT and AAE [21]. In other countries, AAIs involve, in addition to domesticated animals, more exotic species (e.g., dolphin) or others such as alpaca [43,44,45], as well as small mammals (e.g., guinea pig), employed for improving the physical and mental functioning of both children and adults [46].
The “co-therapies” implies the physical contact between the patients [47] and the animals’ mucosae and fur that cause the exposition of several pathogens carried by animals in a silent way [48,49,50]. Therefore, noteworthy is the dispute about an existing necessity to maintain physical contact during AAI and prevent the transmission of potential zoonotic agents. Zoonosis is an infectious disease that can be transmitted to humans from animals and vice versa [51].
The present narrative review focuses on the most common zoonotic agents that can be transmitted from animals to humans and the ways of preventing them, to be applied both to the animals and to the patient; in choosing the right animal species according to the single patient’s needs and link that might occur during AAIs, according to the Italian National Guidelines for AAIs 2015 [30]. For this purpose, these guidelines include (a) specific AAI training for each figure involved in AAI (veterinarian, animal handler, etc.); (b) the establishment of a regional register of traders and facilities; (c) health, welfare, and behavioral criteria for the animals involved; and (d) the scientific evaluation of the results of projects performed [21]. The narrative review also intends to focus on the benefits/challenges of AAIs for this purpose. Four electronic scientific databases have been consulted: PubMed, Web of Science, SCOPUS, and Google Scholar. The search of documents for this narrative review was performed in January 2023, by two of the authors (GL and AC) independently, using five strings that represent subject heading and text words related to our topic (see: Table 1).

2. Potential Zoonoses Associated with Dogs

The dog represents the mainly involved animal species in AAIs as well as in hospital-based AAT in pediatric oncology patients [47]. Although substantial benefits have been documented in the literature on the involvement of dogs in AAI, physical contact between humans and animals could cause the carrying of potential pathogens from animals to human beings. Sometimes, in AAI settings the dogs employed might also represent pathogen carriers causing a pathogen exchange from being contaminated by physical contact with infected/haunted subjects and then transferring microorganisms to other patients [2,52]. In particular, it is scientifically demonstrated that pediatric oncological patients have immunodeficiency cancer treatments mediated and therefore are retained to be more susceptible [2,47]. The modes of pathogens transmission can include physical interaction, aerosol inhalation, infected saliva, urine, or feces, as well as contact with contaminated tools [53].
Several transmissible diseases that can be transmitted by dogs to patients (see Table 2) consist of viral pathogens (Norovirus, rabies) [54], microorganisms of bacterial origin such as Bordetella bronchiseptica-associated disease, Brucellosis, Capnocytophagosis, Coxiellosis, Cryptosporidiosis, Infections with E. coli, Leptospirosis, Methicillin resistance Staphylococcus aureus, MRSA, including Campylobacter spp, such as C. jejuni, and C. coli [55]. The most common risk factors associated with Campylobacter spp. occurrence are represented by the dog’s breed and diet, while differences in age and sex of the animal do not seem to have statistical significance.
Considering that younger dogs have an immature immune system and a poorly developed gut microbiota, therefore unable to induce the competitive exclusion principle toward microorganisms, Campylobacter spp. incidence is more easily found in the latter [56]. In addition, purebred dogs seem to be more easily exposed to Campylobacter spp. coinfection if compared to crossbreed dogs, which appear generally more resistant to disease [56]. Another potential risk for dogs is Campylobacter spp. transmission from homemade cooked food, especially meat, and is sometimes associated with incorrect food handling and/or cross-contamination from raw foods [55,57]. Dogs involved in AAIs should not be fed raw animal-origin foods within 90 days before service [58,59]
Still, other pathogens that cause zoonoses and could be found in dogs are Pasterurellosis, Salmonellosis, Staphylococcal pyoderma, Tularemia cutaneus, Yersiniosis enterocolitica, fungal contamination, ringworms, parasites (Echinococcosis, Giardiasis, Mange), and visceral larva migrans [2,53,60,61].
The adoption of different practices and protocols can modulate safety results and outcomes [2,62].
Protocols to evaluate zoonotic-pathogens transmission consist of group A streptococci, Clostridium difficile, vancomycin-resistant enterococci, and MRSA [58]. The majority of zoonoses are commonly identified and treated. Preventive measures involve internal and external parasite treatments and vaccination protocols; taken together, they are environmental biomonitoring to safeguard both dogs’ and human health [2,53]. An Italian study showed that the most common high-risk zoonotic agents of parasitic origin included Ancylostomatidae, Eucoleus aerophylus, Toxocara canis, Giardia duodenalis, Nannizzia gypsea, and Paraphyton mirabile [63].
The risk of pathogen transmission depends on contact and time of exposure to the pathogens; therefore, the duration of an AAT session varies from 15 to 120 min, with increasing intensification of the physical contact between the animal and the patient [4,5,6,64].
Another problem that can be found in AAIs is the patient’s or family’s fear of dogs; one of the exclusion criteria of an animal involved in AAI in such circumstances. In fact, the exclusion criteria can include fear/phobia of animals, cultural attitudes [65]; unsafe animal behavior [66]; injuries, such as a fall or bites and scratches, which can happen if handled inappropriately or an inappropriate animal for the therapy environment is chosen [25,67]; allergic reactions such as pet dander [68]; as well as concerns regarding hygiene/sanitization [68].
Most protocols suggest that dogs undergo washing and grooming by 24 h prior to contact with patients [69]. Nevertheless, washing a dog a couple of times during the week can reduce Can f1 from dog hair and coat, lowering the risk of allergic reaction [25]. Allergies can cause skin irritations, rhinoconjunctivitis, and bronchial asthma, representing a precise contraindication for (in)direct contact with dogs [25]. Up to now, there is no evidence of the presence of a hypoallergenic dog breed [68].
Then, from a welfare point of view, the allergological risks of implementing dogs in a hospital or outpatient setting should not be underestimated [68], and these animals should not interact with patients suffering from allergic asthma. In addition, emergency medication should be available to a trained person on site to mitigate risk in the event of an allergic response [68,70].
Table 2. Potential pathogens and the preventive measures to reduce/eliminate the zoonotic risk in AAIs.
Table 2. Potential pathogens and the preventive measures to reduce/eliminate the zoonotic risk in AAIs.
Animal SpeciesZoonotic AgentsReferencesPreventive Measures
DogViruses: Norovirus
Lyssavirus: Rabies virus
Bacterial infections: Bordetella bronchiseptica-associated disease
Brucellosis, Campylobacteriosis, Capnocytophagosis, Coxiellosis,
Cryptosporidiosis, E. coli, Leptospirosis,
Methicillin resistance Staphylococcus aureus (MRSA), Campylobacter jejuni, and C. coli
Group A Streptococci, Clostridium difficile, vancomycin-resistant enterococci, Pasterurellosis, Salmonellosis,
Staphylococcal pyoderma, Tularemia cutaneus, Yersiniosis enterocolitica
Fungal infections:
ringworms;
Parasites: Echinococcosis,
Mange
visceral larva migrans
 
Ancylostomatidae, Eucoleus aerophylus, Toxocara canis, Giardia duodenalis, Nannizzia gypsea,
Paraphyton mirabile
 
 
 
 
 
 
[38,54]
 
 
 
 
 
 
 
 
[58]
 
 
 
 
[2,53,60,61]
 
 
 
 
 
[63]
Basic sanitation practices
Internal and external parasites treatments
Vaccinations
Environmental control
[2,53]
CatViruses: cowpox, rabies
Bacteria: Bacillus anthracis, Bartonella species, Borrelia burgdorferi,
group A streptococcus, Listeria monocytogenes, Rickettsia felis,
salmonella species,
Tapeworms: Dipylidium caninum, Echinococcus multilocularis,
Ectoparasites: Cheyletiella blakei,
Sarcoptes scabiei, Roundworms: Ancylostoma braziliense, Hearthworm: Dirofilaria immitis, Strongyloides stercoralis,
Uncinaria stenocephala;
Fungi: Microsporum species, Trichophyton species;
Protozoans: Toxoplasma gondii
[71]
 
 
 
[72]
Basic sanitation practises
Vaccination
Regular testings
Deworming
Good hygiene
[71]
Vaccination
long-term safety of an anti-Fel d 1 IgY-supplemented diet [72]
RabbitBacteria:Pasteurella multocida
Protozoa:cryptosporidium
 
 
External parasites: Cheyletiella (acariasis), Dermatophytosis Trichophyton
[73]
 
[74,75]
Best sanitation practices
[73]
HorseViruses: Borna Disease Virus-1
Alphavirus, Hendravirus, Lyssavirus
Group-A-Rotavirus, Vesiculovirus
Flavivirus
Bacteria: Anaplasma phagocytophilum
Bacillus antracis, Clostridium botulinum
Brucella abortus and B suis
Clostridium difficile, Burgholderia mallei, Leptospira interrogans,
Borrelia burgdorferi, Strains of Staphylococcus aureus, Rhodococcus equi, salmonella enterica ssp enterica serovar typhimurium, Streptococcus equi ssp zooepidemicus, Clostridium tetani, Mycobacteria avium, bovis, and tuberculosis,
Protozoa: Cryptosporidium parvum, Giardia intestinalis, Toxoplasma gondii, Trichinella
Fungi: Microsporum canis, Micosporum gypseum, Trichophyton mentagrophytes, Trichophyton equinum
[76]Basic sanitation practices
Healthy environment, vaccines [76]
DonkeyViruses: Equine encephalomyelitis, Rabies,
Protozoa: Toxoplasma
Tapeworm: Hydatidosis,
[77]Best sanitation practices
Regular anti ecto- and endo-zoonotic parasites treatments,
Personal and environmental hygiene, regular dermatophytosis monitor [63]

3. Potential Zoonoses Associated with Cat-Assisted Interventions

Potential zoonotic diseases from cats that can infect humans are listed in Table 2. The most common zoonotic diseases that can be transmitted by cats include Bacillus anthracis, Bartonella species, Borrelia burgdorferi, group A streptococcus, Listeria monocytogenes, Rickettsia felis, salmonella species, tapeworms (Dipylidium caninum, Echinococcus multilocularis), ectoparasites (Cheyletiella blakei, Sarcoptes scabiei), Roundworms (Ancylostoma braziliense), heartworm (Dirofilaria immitis, Strongyloides stercoralis, Uncinaria stenocephala); fungi (Microsporum species, Trichophyton species); protozoans (Toxoplasma gondii); viruses (cowpox, rabies). Some cat-associated zoonoses, such as rabies, are prevented through vaccination. Other infections can be prevented or eliminated through regular testing and the deworming of the animals by veterinarians. In addition, good hygiene should always be maintained around animals.
Another aspect of involving cats is the expression of allergic symptoms from the patients or their relatives. Allergy to cat fur depends on the presence and spread out of the Fel D1 major antigen found in their saliva and dander [72]. This allergen is produced more by entire male cats than neutered males (due to a partial influence from testosterone) [78,79,80,81,82] and females. No scientific data can confirm the presence of less allergenic breeds of cats [72]. Two strategies to reduce the problem could be summarized as follows: 1. Vaccination of cats against the allergen Fel d 1 secretion, not commercially available yet; 2. Long-term safety of an anti-Fel d 1 IgY-supplemented diet, available commercially. The availability of this diet helps the veterinary healthcare team to organize, with both owners and human healthcare professionals, measures that can be taken to reduce the environmental burden of Fel d 1 [72] or in extreme cases choosing a different animal species for the therapy.
An integrated approach targeting the mechanisms causing allergy by dog or cat include allergenic immunotherapy (AIT), subcutaneous-(SCIT) or sublingual-(SLIT) immunotherapy, patient education, allergen avoidance, and pharmacotherapy.

4. Potential Zoonoses Associated with Rabbit-Assisted Interventions

The literature referring to this species is almost scarce and only a few data were possible to be extracted (see Table 2). Rabbits are generally docile animals that are easy to handle, with a low risk of transmitting zoonotic pathogens [73]. The greater risk when working with rabbits is to develop allergies while biting is uncommon. Specific handling techniques and appropriate protective clothes are necessary to avoid painful scratches with their rear limbs when improperly handled.
Diseases of public health importance in domestic rabbits are rare. The development of disease in the human host usually occurs in the presence of a preexisting compromised immune system. Potential rabbit zoonoses include Pasteurella multocida (the bacterium that lives in the oral cavity or upper respiratory tract of rabbits and can be transferred to humans by bites or scratch) [73], Cryptosporidiosis, induced by Cryptosporidium, an extracellular protozoal organism, which is transmitted via the fecal–oral route [74,75]. Other rabbit diseases such as salmonellosis, yersiniosis, and tularemia are rare and can be transmitted to humans by wild rabbits. External parasites such as acariasis (Cheyletiella) and dermatophytosis (Trichophyton) may be transmitted to humans [75].

5. Potential Zoonoses Associated with Equine-Assisted Interventions

Several infectious diseases can affect both horses and humans (see Table 2). Zoonotic agents represent the interconnection between human beings, the environment, and animals [83], thus, their transmission from horse to human can occur through direct contact (e.g., Hendra virus) or indirect contamination such as food products (e.g., Botulism) or vectors like ticks (e.g., Lyme-Borrelioses) and mosquitos (e.g., West Nile Fever) [84]. Therefore, the incidence of zoonotic-pathogens transmission has a close relation to the immune system of the animal and human beings, pathogen-control protocols, and environmental influence [85]. The frequency of zoonotic diseases is strictly under control [83]. No findings have been found on reverse zoonosis, which is a disease that was transmitted from human to horse.
Novel pathogens seem to have a relevant impact on horse/human health and relationships. The most emblematic case of emerging disease is the Hendra virus (HeV), which was considered the leading cause of mortality in both human beings and horses in Australia. This virus is a part of the paramyxoviridae genus, which has as a natural reservoir the flying foxes. The transmission way of the above virus is the direct contact of people with the secretions of contaminated horses [86]. Middleton and coworkers (2014) [87] developed an anti-HeV vaccine for horses that provided health benefits to humans as well as to environmental health too, meeting the spirit of a One Health approach. Recently, the pandemic of coronavirus disease 2019 (COVID-19) has triggered possible questions regarding the involvement of horses as virus reservoirs. In the USA it was described that about 10% of horses were positive for β-coronavirus [88], one of the potential sources of COVID-19. At present, no scientific evidence of a direct relationship between human coronavirus and that of horses has been reported [52]. No literature has been detected regarding the direct transmission of equine-human zoonotic agents during EAI. The public should be instructed and trained before interacting with the horse; furthermore, legislation with formal and social permission to work with the horse should be necessary. While integrated medicine is now related to zoonosis prevention, other One Health aspects are important, such as pathogen-control protocols and manufacturing, safety, and quality control of vaccines as well [76].
Among equine species, donkeys are also employed in assisted therapy in elderly people with mental disorders [89,90] or children with autism spectrum or motor disabilities [91,92]. These animals seem to be excellent facilitators in the motivation-building process, being able to stimulate the child’s development promoting psychoaffective and psychocognitive development processes [91]. The most important selective feature of donkeys for AT is their temperament evaluated by numerous behavioral tests used in horses too [93]. Nevertheless, knowledge of donkeys’ responses to standardized behavioral tests should be improved [94]. As reported by De Rose et al. (2011) [91], the choice of the donkey is based on its ethological characteristics, primarily its size, which makes the donkey an unavoidable but not intimidating interlocutor. Thanks to its physical structure, the donkey is physically well-accepted, offering an opportunity for contact and space sharing. When confronted with a new situation, the donkey is neither impulsive nor anxious and instinctively curious [94,95].
No literature regarding zoonotic agents’ transmission from donkeys during AAIs has been found, with the exception of Hydatidosis and toxoplasma infections where their zoonotic potentials have been studied more. Bacterial zoonoses such as brucellosis, leptospirosis, and salmonellosis have been described mainly in equine. In contrast, rabies and Equine encephalomyelitis viral infection have been reported in donkeys more than any other viral zoonoses [77].
The prevention and control measures put in place and the education of the public about them represent the way to prevent possible human infections.

6. Discussion

The human–animal bond existed for thousands of years and such a relationship is important for veterinary medicine and human health and wellbeing [96,97]. Veterinarians’ involvement in AAIs is crucial because they serve for the health and welfare of animals participating in these programs and as experts in zoonotic disease transmission. Nevertheless, AAIs might be regulated by basic procedures, be closely supervised, and have adequately trained operators. The health and welfare conditions of the human beings and animals involved should be guaranteed.
Since veterinary medicine serves society, it fulfills both human and animal needs. Veterinarians, as professionals, are qualified to provide community service via such programs and to aid in the scientific evaluation and documentation of the health benefits or risks of animal-assisted interventions [96]. Involving animals in AAIs has become a common extensive practice. However, different practices and protocols used across institutions could potentially compromise the outcomes, safety, and findings [2]. An Animal Assisted Intervention International Standards of Practice [98] help and encourage individuals, organizations, institutions, and health and human service providers who are interested in or are organizing an AAI program. These standards represent the minimum necessary to conduct an AAI program for Animal Assisted Intervention International (AAII) members. These programs should also meet any standards or regulations requested by governing bodies for their region and their home organization [98]. Such AAII standards of practice refer to dogs but can be extended and applied to all different animal species employed in AAIs. Despite these benefits, AAIs also show problems, such as allergies, asthma, animal bites and scratches, and human falls. Bites, slips, and falls from animals, dogs, and, to a lesser extent, cats might be the most troublesome animal-associated health hazard [99] in terms of seriousness, frequency, and cost. Moreover, for the most troublesome breeds, the importance of good temperament and the need for schooling could be incorporated into guidelines to reduce the risk of injuries in an AAI program. It is reasonable to suggest that, in a well-supervised environment such as a hospital ward, after careful selection of the AAI animal involved, the risks of animal bites are minimal and should not prevent the implementation of such therapy. In fact, animal-related accidents have to be considered very rare although they can happen. For that, appropriate reviews and guidelines implement all security precautions effectively minimizing risks [25,67].
One of the most important problems regarding AAIs is the fear of transmission of zoonotic disease, allergies, and injuries, in particular in immunodeficient or immunocompromised subjects such as pediatric oncological patients or heart transplanted subjects [2,47,100]. Thus, the choice of an appropriate animal and activity program is fundamental [47,101].
As regards the fear of disease transmission, veterinarians should be more actively involved. The presence of veterinarians in the hospitals is mainly requested by the animal owner, according to hospital policies. Acquiring the veterinarian, a pivotal role in a team including hospital operators, could improve the focal point on the wellbeing of animals, mitigating the possible spread of disease and enhancing the benefit of the AAIs [102,103]. In addition, veterinarians participating in AAI sessions could also facilitate relations with hospital administration and staff and the AAI operators in the development of procedures finalized to reduce the risk and improve benefits to humans and safeguard the welfare of the “animal therapists”. Thus, screening and vaccinations should be discussed, for the zoonosis associated with any animal species involved in the AAI with veterinarians. Moreover, veterinarians must be strictly involved with the staff performing clinical protocols for AAI in both oncologic and care settings according to a One Health approach [2]. This vision is in line with the International Association of Human-Animal Interaction Organizations (IAHAIO) AAI guidelines and constitutes the maximum expression of circular health according to the One Health principle [28,104,105,106,107]. On this basis, we could realize that AAIs represent a wide range of relational feedbacks characterized first by bodily attitudes and subsequently by sensory–motor–emotional patterns between the two species. Although different animal species are involved in AAIs [25,108,109], dogs are preferred because they seem to facilitate a greater mutual relationship and deeper therapeutic work [109]. Moreover, for its ethological features such as relationship, communication and interaction, and similarities with the children, the dog learns through games [110]. In fact, dogs are considered the most well-established animals involved in AAIs directly in hospitals, daycare centers, or homes for the elderly offering many advantages, particularly for those clients affected by mental disorders or forced to stay in those facilities for a long time [111,112,113]. Involving dogs in AAIs has several benefits that are greater [114,115,116] than the risks. Some find potential stress or welfare risks in dogs occur that might limit or even avoid the involvement of dogs in the therapies. Generally, small dogs are certainly the most well-established AAI. Thus, a careful evaluation of the dogs employed of different sizes and breeds in an AAI program would be necessary [100].
The purpose of the different types of AAIs is the planning of games that the handler, with a practiced doctor or psychologist, conducts on the basis of the animal species involved, and its individual characteristics.
A limit of the present review deals with the few data describing zoonosis, habits, advantages, and regulations managing the employment of the numerous nonofficial or nonconventional animal species in the AAIs in different countries. Thus, an official list of the specialized centers and recognized structures, professionals involved, AAIs projects, and identification number of the AAI animals involved, in each country, would improve the quality level of AAI programs. Such lists should be managed by the regional/national authorities, in order to guarantee the qualifications of the professionals. This program just started in Italy [30]. Thus, national institutions, by determining boundaries and providing indications for the correct implementation of AAIs, would assure protection for both the humans and animals involved enhancing the safety and effectiveness of the interventions, and their overall quality [30].

7. Future Directions

The synergy among veterinarians, public health professionals, and epidemiologists, has a key role in preventing zoonotic disease transmission to safeguard the health of humans, animals, and the environment, in accordance with a One Health vision. AAIs, and more specifically the AAT, and the AAA in the health sector, constitute a tangible representation of the One Health perspective and therefore, necessitate a multidisciplinary/intersectoral approach between the different health professional figures who, each according to their own skills, work in a specialized team for the prevention and control of zoonoses, the health and welfare of people, the animals involved, and the environment.
Furthermore, we would build an action plan among different international experts in the field of AAI in order to formulate standardized hygiene–health–behavioral procedures, with the ultimate aim of establishing univocal health and behavioral certifications for all animals performing AAT and AAA in the healthcare field.

8. Conclusions

In conclusion, since zoonoses are considered public health problems, the use of a multidisciplinary and integrated One Health approach is necessary for their resolution. This strategy provides for a series of synergies aimed at surveillance, monitoring, and prevention, as well as the improvement of training/information/dissemination. As described in the literature, AATs are finalized for the treatment of various types of pathologies and with a state of immunocompromise or immunosuppression. Veterinarians’ involvement in these programs is crucial because they serve the health and welfare of animals participating in these programs and as experts in preventing zoonotic disease transmission. On this basis, we might hypothesize that a correct procedural protocol including a preventive, integrated, and multidisciplinary approach, will represent the future development of AAIs. Furthermore, a benefit/challenge analysis carried out in this review allows us to hypothesize that, by applying preventive measures, AAIs could be considered as cotherapy for specific pathologies and safe under the hygienic-sanitary point of view for the patients treated, for the operators, and for the animals involved.

Author Contributions

Conceptualization, G.L. and A.C.; writing—original draft preparation, A.C., G.L. and R.L.; writing—review and editing, A.C., G.L. and R.L.; supervision, A.G. and O.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors are grateful to Luigi Urbano, Prevention Department of Local Health Authority Director, to have developed AAIs promotion.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Santaniello, A.; Sansone, M.; Fioretti, A.; Menna, L.F. Systematic Review and Meta-Analysis of the Occurrence of ESKAPE Bacteria Group in Dogs, and the Related Zoonotic Risk in Animal-Assisted Therapy, and in Animal-Assisted Activity in the Health Context. Int. J. Environ. Res. Public Health 2020, 17, 3278. [Google Scholar] [CrossRef] [PubMed]
  2. Cotoc, C.; Notaro, S. Race, Zoonoses and Animal Assisted Interventions in Pediatric Cancer. Int. J. Environ. Res. Public Health 2022, 19, 7772. [Google Scholar] [CrossRef] [PubMed]
  3. Monfort Montolio, M.; Sancho-Pelluz, J. Animal-Assisted Therapy in the Residential Treatment of Dual Pathology. Int. J. Environ. Res. Public Health 2019, 17, 120. [Google Scholar] [CrossRef]
  4. Menna, L.F.; Santaniello, A.; Todisco, M.; Amato, A.; Borrelli, L.; Scandurra, C.; Fioretti, A. The Human-Animal Relationship as the Focus of Animal-Assisted Interventions: A One Health Approach. Int. J. Environ. Res. Public Health 2019, 16, 3660. [Google Scholar] [CrossRef] [PubMed]
  5. Menna, L.F.; Santaniello, A.; Amato, A.; Ceparano, G.; Di Maggio, A.; Sansone, M.; Formisano, P.; Cimmino, I.; Perruolo, G.; Fioretti, A. Changes of Oxytocin and Serotonin Values in Dialysis Patients after Animal Assisted Activities (AAAs) with a Dog—A Preliminary Study. Animals 2019, 9, 526. [Google Scholar]
  6. Menna, L.F.; Santaniello, A.; Gerardi, F.; Sansone, M.; Di Maggio, A.; Di Palma, A.; Perruolo, G.; D’Esposito, V.; Formisano, P. Eficacy of animal-assisted therapy adapted to reality orientation therapy: Measurement of salivary cortisol. Psychogeriatrics 2019, 19, 510–512. [Google Scholar] [CrossRef]
  7. Hediger, K.; Meisser, A.; Zinsstag, J. A One Health Research Framework for Animal-Assisted Interventions. Int. J. Environ. Res. Public Health 2019, 16, 640. [Google Scholar] [CrossRef]
  8. Wijker, C.; Leontjevas, R.; Spek, A.; Enders-Slegers, M.J. Effects of Dog Assisted Therapy for Adults with Autism Spectrum Disorder: An Exploratory Randomized Controlled Trial. J. Autism Dev. Disord. 2020, 50, 2153–2163. [Google Scholar] [CrossRef]
  9. Zafra-Tanaka, J.H.; Pacheco-Barrios, K.; Tellez, W.A.; Taype-Rondan, A. Effects of dog-assisted therapy in adults with dementia: A systematic review and meta-analysis. BMC Psychiatry 2019, 19, 41. [Google Scholar] [CrossRef]
  10. Menna, L.F.; Santaniello, A.; Gerardi, F.; Di Maggio, A.; Milan, G. Evaluation of the efficacy of animal-assisted therapy based on the reality orientation therapy protocol in Alzheimer’s disease patients: A pilot study. Psychogeriatrics 2016, 16, 240–246. [Google Scholar] [CrossRef]
  11. Jones, M.G.; Rice, S.M.; Cotton, S.M. Incorporating animal-assisted therapy in mental health treatments for adolescents: A systematic review of canine assisted psychotherapy. PLoS ONE 2019, 14, e0210761. [Google Scholar] [CrossRef] [PubMed]
  12. Hediger, K.; Wagner, J.; Künzi, P.; Haefeli, A.; Theis, F.; Grob, C.; Pauli, E.; Gerger, H. Effectiveness of animal-assisted interventions for children and adults with post-traumatic stress disorder symptoms: A systematic review and meta-analysis. Eur. J. Psychotraumatol. 2021, 12, 1879713. [Google Scholar] [CrossRef] [PubMed]
  13. Johnson, R.A.; Albright, D.L.; Marzolf, J.R.; Bibbo, J.L.; Yaglom, H.D.; Crowder, S.M.; Carlisle, G.K.; Willard, A.; Russell, C.L.; Grindler, K.; et al. Effects of therapeutic horseback riding on post-traumatic stress disorder in military veterans. Mil. Med. Res. 2018, 5, 3. [Google Scholar] [CrossRef] [PubMed]
  14. Beetz, A.; Schöfmann, I.; Girgensohn, R.; Braas, R.; Ernst, C. Positive Effects of a Short-Term Dog-Assisted Intervention for Soldiers with Post-traumatic Stress Disorder—A Pilot Study. Front. Vet. Sci. 2019, 6, 170. [Google Scholar] [CrossRef] [PubMed]
  15. Peppe, A.; Costa, A.; Cerino, S.; Caltagirone, C.; Alleva, E.; Borgi, M.; Cirulli, F. Targeting gait and life quality in persons with Parkinson’s disease: Potential benefits of Equine-Assisted Interventions. Park. Relat. Disord. 2018, 47, 94–95. [Google Scholar] [CrossRef]
  16. Mandrá, P.P.; Moretti, T.C.D.F.; Avezum, L.A.; Kuroishi, R.C.S. Animal assisted therapy: Systematic review of literature. Codas 2019, 31, e20180243. [Google Scholar] [CrossRef] [PubMed]
  17. Chalmers, D.; Dell, C.A. Applying One Health to the Study of Animal-Assisted Interventions. Ecohealth 2015, 12, 560–562. [Google Scholar] [CrossRef] [PubMed]
  18. Menna, L.F.; Fontanella, M.; Santaniello, A.; Ammendola, E.; Travaglino, M.; Mugnai, F.; Di Maggio, A.; Fioretti, A. Evaluation of social relationship in elderly by animal-assisted activity. Int. Psychogeriatr. 2012, 24, 1019–1020. [Google Scholar] [CrossRef] [PubMed]
  19. Perkins, J.; Bartlett, H.; Travers, C.; Rand, J. Dog-assisted therapy for older people with dementia: A review. Australas. J. Ageing 2008, 27, 177–182. [Google Scholar] [CrossRef] [PubMed]
  20. Lebov, J.; Grieger, K.; Womack, D.; Zaccaro, D.; Whitehead, N.; Kowalcyk, B.; MacDonald, P.D.M. Aframework for One Health research. One Health 2017, 3, 44–50. [Google Scholar] [CrossRef]
  21. De Santis, M.; Contalbrigo, L.; Simonato, M.; Ruzza, M.; Toson, M.; Farina, L. Animal assisted interventions in practice: Mapping Italian providers. Vet. Ital. 2018, 54, 323–332. [Google Scholar] [PubMed]
  22. Cirulli, F. Animali Terapeuti: Manuale Introduttivo al Mondo della Pet Therapy [Therapists Animals: Getting Started in the World of Pet Therapy]; Carocci Editore: Roma, Italy, 2013. [Google Scholar]
  23. Julius, H.; Beetz, A.; Kotrschal, K.; Turner, D.; Uvnäs-Moberg, K. L’attaccamento agli Animali: Una Visione Integrata della Relazione Uomo-Animale Nella Pet Therapy. [Attachment to Pets: An Integrative View of Human-Animal Relationship with Implications for Therapeutic Practice]; Hogrefe Editore: Firenze, Italy, 2014. [Google Scholar]
  24. Fine, A.H.; Beck, A. Understanding our kinship with animals: Input for health care professionals interested in the human/animal bond. In Handbook on Animal-Assisted Therapy: Theoretical Foundations and Guidelines for Practice; Fine, A.H., Ed.; Academic Press: San Diego, CA, USA, 2010; pp. 3–15. [Google Scholar]
  25. Bert, F.; Gualano, M.R.; Camussi, E.; Pieve, G.; Voglino, G.; Siliquini, R. Animal assisted intervention: A systematic review of benefits and risks. Eur. J. Integr. Med. 2016, 8, 695–706. [Google Scholar] [CrossRef]
  26. Clower, T.L.; Neaves, T.T. The Health Care Cost Savings of Pet Ownership (Report); Human Animal Bond Research Initiative (HABRI) Foundation: Washington, DC, USA, 2015. [Google Scholar]
  27. Italian National Committee for Bioethics. Problemi Bioetici Relativi All’Impiego di Animali in Attività Correlate alla Salute e al Benessere Umani [Bioethical Issues Concerning the Use of Animals in Activities Related to Human Health and Well-Being]. (Discussion Paper of 21 October 2005). 2005. Available online: http://presidenza.governo.it/bioetica/testi/Pet_Therapy.pdf (accessed on 9 February 2023).
  28. IAHAIO. IAHAIO White Paper. The IAHAIO definitions for Animal Assisted Interventions and Guidelines for Wellness of Animals Involved. 2014. Available online: http://www.iahaio.org/new/fileuploads/9313IAHAIO%20WHITE%20PAPER%20TASK%20FORCE%20-%20FINAL%20REPORT.pdf.IAHAIO (accessed on 9 February 2023).
  29. SCAS. Animal-Assisted Interventions: Code of Practice for the UK (Version 1.9). 2013. Available online: http://www.scas.org.uk/wp-content/uploads/2013/06/AAI-Code-of-Practice-SCAS-June-2013.pdf (accessed on 9 February 2023).
  30. Simonato, M.; De Santis, M.; Contalbrigo, L.; Benedetti, D.; Finocchi Mahne, E.; Santucci, V.U.; Borrello, S.; Farina, L. The Italian Agreement between the Government and the Regional Authorities: National Guidelines for AAI and Institutional Context. People Anim. Int. J. Res. Pract. 2018, 1, 1. [Google Scholar]
  31. Badin, L.; Émilie, A.; Pothier, C.; Bailly, N. Effects of equine-assisted interventions on older adults’ health: A systematic review. Int. J. Nurs. Sci. 2022, 9, 542–552. [Google Scholar] [CrossRef] [PubMed]
  32. Palsdottir, A.M.; Gudmundsson, M.; Grahn, P. Equine-assisted intervention to improve perceived value of everyday occupations and quality of life in people with lifelong neurological disorders: A prospective controlled study. Int. J. Environ. Res. Public Health 2020, 17, 2431. [Google Scholar] [CrossRef] [PubMed]
  33. Earles, J.L.; Vernon, L.L.; Yetz, J.P. Equine-assisted therapy for anxiety and posttraumatic stress symptoms. J. Trauma. Stress 2015, 28, 149e52. [Google Scholar] [CrossRef]
  34. Nurenberg, J.R.; Schleifer, S.J. Equine assisted therapy for patients with severe chronic psychiatric disorders. Eur. Psychiatry 2011, 26, 1325. [Google Scholar] [CrossRef]
  35. Borgi, M.; Loliva, D.; Cerino, S.; Chiarotti, F.; Venerosi, A.; Bramini, M.; Nonnis, E.; Marcelli, M.; Vinti, C.; De Santis, C.; et al. Effectiveness of a standardized equine-assisted therapy program for children with autism spectrum disorder. J. Autism Dev. Disord. 2016, 46, 1.e9. [Google Scholar] [CrossRef]
  36. Ajzenman, H.F.; Standeven, J.W.; Shurtleff, T.L. Effect of Hippotherapy on Motor Control, Adaptive Behaviors, and Participation in Children with Autism Spectrum Disorder: A Pilot Study. Am. J. Occup. Ther. 2013, 67, 653–663. [Google Scholar] [CrossRef]
  37. Champagne, D.; Dugas, C. Improving gross motor function and postural control with hippotherapy in children with Down syndrome: Case reports. Physiother. Theory Pract. 2010, 26, 564–571. [Google Scholar] [CrossRef]
  38. Beinotti, F.; Christofoletti, G.; Correia, N.; Borges, G. Effects of Horseback Riding Therapy on Quality of Life in Patients Post Stroke. Top. Stroke Rehabil. 2013, 20, 226–232. [Google Scholar] [CrossRef] [PubMed]
  39. Sung, Y.H.; Kim, C.J.; Yu, B.K.; Kim, K.M. A hippotherapy simulator is effective to shift weight bearing toward the affected side during gait in patients with stroke. NeuroRehabilitation 2013, 33, 407–412. [Google Scholar] [CrossRef] [PubMed]
  40. Zadnikar, M.; Kastrin, A. Effects of hippotherapy and therapeutic horseback riding on postural control or balance in children with cerebral palsy: A meta-analysis. Dev. Med. Child Neurol. 2011, 53, 684–691. [Google Scholar] [CrossRef] [PubMed]
  41. Wollenweber, V.; Drache, M.; Schickendantz, S.; Gerber-Grote, A.; Schiller, P.; Pohlau, D. Study of the eectiveness of hippotherapy on the symptoms of multiple sclerosis-Outline of a randomised controlled multicentre study (MS-HIPPO). Contemp. Clin. Trials Commun. 2016, 3, 6–11. [Google Scholar] [CrossRef]
  42. Winchester, P.; Kendall, K.; Peters, H.; Sears, N.; Winkley, T. The eect of therapeutic horseback riding on gross motor function and gait speed in children who are developmentally delayed. Phys. Occup. Pediatr. 2002, 22, 37–50. [Google Scholar] [CrossRef]
  43. Liguori, G.; Pelagalli, A.; Assisi, L.; Squillacioti, C.; Costagliola, A.; Mirabella, N. Effects of orexins on 17β-estradiol synthesis and P450 aromatase modulation in the testis of alpaca (Vicugna pacos). Anim Reprod Sci. 2018, 192, 313–320. Available online: https://pubmed.ncbi.nlm.nih.gov/29622348 (accessed on 26 March 2023). [CrossRef]
  44. Liguori, G.; Squillacioti, C.; Assisi, L.; Mirabella, N.; Langella, E.; Costagliola, A.; Vittoria, A. Localization of orexin B and receptor 2 for orexins in testicular cytotypes of the camelid alpaca (Vicugna pacos). Reprod Domest Anim. 2017, 52, 452–458. Available online: https://pubmed.ncbi.nlm.nih.gov/28181310 (accessed on 26 March 2023). [CrossRef]
  45. Liguori, G.; Paino, S.; Mirabella, N.; Squillacioti, C.; De Luca, A.; Vittoria, A. Expression of orexin A and its receptor 1 in the epididymis of the South American camelid alpaca (Vicugna pacos). Anat. Histol. Embryol. 2014, 43, 42–47. Available online: https://pubmed.ncbi.nlm.nih.gov/23521689 (accessed on 26 March 2023). [CrossRef]
  46. Kapustka, J.; Budzyńska, M. Reproductive Losses and Their Causes in Alpacas—A Survey-Based Study. Animals 2022, 12, 3030. [Google Scholar] [CrossRef]
  47. Fiumana, G.; Botta, D.; Dalla Porta, M.F.; Macchi, S.; Soncini, E.; Santaniello, A.; Paciello, O.; Amicucci, M.; Cellini, M.; Cesaro, S. Consensus Statement on Animals’ Relationship with Pediatric Oncohematological Patients, on Behalf of Infectious Diseases and Nurse Working Groups of the Italian Association of Pediatric Hematology–Oncology. J. Clin. Med. 2023, 12, 2481. [Google Scholar] [CrossRef]
  48. Maurelli, M.P.; Santaniello, A.; Fioretti, A.; Cringoli, G.; Rinaldi, L.; Menna, L.F. The Presence of Toxocara Eggs on Dog’s Fur as Potential Zoonotic Risk in Animal-Assisted Interventions: A Systematic Review. Animals 2019, 9, 827. [Google Scholar] [CrossRef] [PubMed]
  49. Boyle, S.F.; Corrigan, V.K.; Buechner-Maxwell, V.; Pierce, B.J. Evaluation of Risk of Zoonotic Pathogen Transmission in a University-Based Animal Assisted Intervention (AAI) Program. Front. Vet. Sci. 2019, 6, 167. [Google Scholar]
  50. Gerardi, F.; Santaniello, A.; Del Prete, L.; Maurelli, M.P.; Menna, L.F.; Rinaldi, L. Parasitic infections in dogs involved in animal-assisted interventions. Ital. J. Anim. Sci. 2018, 1, 269–272. [Google Scholar] [CrossRef]
  51. Zoonoses—World Health Organization (WHO). 29 July 2020. Available online: https://www.who.int/news-room/fact-sheets/detail/zoonoses (accessed on 9 February 2023).
  52. Costagliola, A.; Liguori, G.; d’Angelo, D.; Costa, C.; Ciani, F.; Giordano, A. Do Animals Play a Role in the Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)? A Commentary. Animals 2020, 11, 16. [Google Scholar] [CrossRef] [PubMed]
  53. Stull, J.W.; Brophy, J.; Weese, J.S. Reducing the risk of pet-associated zoonotic infections. CMAJ 2015, 187, 736–743. [Google Scholar] [CrossRef]
  54. Charoenkul, K.; Nasamran, C.; Janetanakit, T.; Tangwangvivat, R.; Bunpapong, N.; Boonyapisitsopa, S.; Suwannakarn, K.; Theamboonler, A.; Chuchaona, W.; Poovorawan, Y.; et al. Human Norovirus Infection in Dogs, Thailand. Emerg. Infect. Dis. 2020, 26, 350–353. [Google Scholar] [CrossRef]
  55. Santaniello, A.; Varriale, L.; Dipineto, L.; Borrelli, L.; Pace, A.; Fioretti, A.; Menna, L.F. Presence of Campylobacter jejuni and C. coli in Dogs under Training for Animal-Assisted Therapies. Int. J. Environ. Res. Public Health 2021, 18, 3717. [Google Scholar] [CrossRef]
  56. Karama, M.; Cenci-Goga, B.T.; Prosperi, A.; Etter, E.; El-Ashram, S.; McCrindle, C.; Ombui, J.N.; Kalake, A. Prevalence and risk factors associated with Campylobacter spp. occurrence in healthy dogs visiting four rural community veterinary clinics in South Africa. Onderstepoort J. Vet. Res. 2019, 86, e1–e6. [Google Scholar] [CrossRef]
  57. Leonard, E.K.; Pearl, D.L.; Janecko, N.; Weese, J.S.; Reid-Smith, R.J.; Peregrine, A.S.; Finley, R.L. Factors related to Campylobacter spp. carriage in client-owned dogs visiting veterinary clinics in a region of Ontario, Canada. Epidemiol. Infect. 2011, 139, 1531–1541. [Google Scholar] [CrossRef]
  58. Lefebvre, S.L.; Peregrine, A.S.; Golab, G.C.; Gumley, N.R.; Waltner-Toews, D.; Weese, J.S. A veterinary perspective on the recently published guidelines for animal-assisted interventions in health-care facilities. J. Am. Vet. Med. Assoc. 2008, 233, 394–402. [Google Scholar] [CrossRef]
  59. Murthy, R.; Bearman, G.; Brown, S.; Bryant, K.; Chinn, R.; Hewlett, A. Animals in healthcare facilities: Recommendations to minimize potential risks. Infect. Control Hosp. Epidemiol. 2015, 36, 495–516. [Google Scholar] [CrossRef] [PubMed]
  60. Rahman, M.T.; Sobur, M.A.; Islam, M.S.; Ievy, S.; Hossain, M.J.; El Zowalaty, M.E.; Rahman, A.T.; Ashour, H.M. Zoonotic Diseases: Etiology, Impact, and Control. Microorganisms 2020, 8, 1405. [Google Scholar] [CrossRef]
  61. Center for Disease Control and Prevention. Healthy Pets, Healthy People. Available online: https://www.cdc.gov/healthypets/index.html (accessed on 9 February 2023).
  62. Chubak, J.; Hawkes, R. Animal-Assisted Activities: Results from a Survey of Top-Ranked Pediatric Oncology Hospitals. J. Pediatr. Oncol. Nurs. 2016, 33, 289–296. [Google Scholar] [CrossRef] [PubMed]
  63. Simonato, G.; Danesi, P.; Frangipane di Regalbono, A.; Dotto, G.; Tessarin, C.; Pietrobelli, M.; Pasotto, D. Surveillance of Zoonotic Parasites in Animals Involved in Animal-Assisted Interventions (AAIs). Int. J. Environ. Res. Public Health 2020, 17, 7914. [Google Scholar] [CrossRef]
  64. Shen, R.Z.Z.; Xiong, P.; Chou, U.I.; Hall, B.J. “We need them as much as they need us”: A systematic review of the qualitative evidence for possible mechanisms of effectiveness of animal-assisted intervention (AAI). Complement. Ther. Med. 2018, 41, 203–207. [Google Scholar] [CrossRef] [PubMed]
  65. Chur-Hansen, A.; McArthur, M.; Winefield, H.; Hanieh, E.; Hazel, S. Animal-assisted interventions in children’s hospitals: A critical review of the literature. Anthrozoös 2014, 27, 5–18. [Google Scholar] [CrossRef]
  66. Friesen, L. Exploring animal-assisted programs with children in school and therapeutic contexts. Early Child. Educ. J. 2010, 37, 261–267. [Google Scholar] [CrossRef]
  67. Brodie, S.J.; Biley, F.C.; Shewring, M. An exploration of the potential risks associated with using pet therapy in healthcare settings. J. Clin. Nurs. 2002, 11, 444–456. [Google Scholar] [CrossRef]
  68. Schmidt, V.; Mokrá, M.; Demolli, P.; Brüggen, M.C.; Möhrenschlager, M. Allergologic pitfalls in animal-assisted interventions. Allergo J. Int. 2022, 31, 45–147. [Google Scholar] [CrossRef]
  69. Lefebvre, S.L.; Golab, G.C.; Christensen, E.; Castrodale, L.; Aureden, K.; Bialachowski, A.; Gumley, N.; Robinson, J.; Peregrine, A.; Benoit, M.; et al. Guidelines for animal-assisted interventions in health care facilities. Am. J. Infect. Control 2008, 36, 78–85. [Google Scholar] [CrossRef]
  70. Toshihiro, S.; Matsui, T.; Suzuki, K.; Chida, K. Effect of pet removal on pet allergic asthma. Chest 2005, 127, 1565–1571. [Google Scholar]
  71. Feline Zoonoses. What I Can Catch from My Cat? 2019. Available online: www.catvets.com (accessed on 9 February 2023).
  72. Sparkes, A.H. Human allergy to cats: A review for veterinarians on prevalence, causes, symptoms and control. J. Feline Med. Surg. 2022, 24, 31–42. [Google Scholar] [CrossRef] [PubMed]
  73. Care and Use of Rabbits: Environmental Health & Safety Occupational Health for Animal Handling. Available online: https://occupationalhealth.oregonstate.edu/rabbits (accessed on 9 February 2023).
  74. Zoonoses: Animals Other Than Dogs and Cats. Available online: https://www.medilib.ir/uptodate/show/5531#rid51 (accessed on 9 February 2023).
  75. Chomel, B.B. Zoonoses of house pets other than dogs, cats and birds. Pediatr. Infect. Dis. J. 1992, 11, 479–487. [Google Scholar] [CrossRef]
  76. Lönker, N.S.; Fechner, K.; Wahed, A.A.E. Horses as a Crucial Part of One Health. Vet. Sci. 2020, 7, 28. [Google Scholar] [CrossRef] [PubMed]
  77. Ngetich, W.; Chepkirui, E. A review of zoonotic pathogens of donkeys (Equus asinus). J. Anim. Sci. Vet. Med. 2020, 5, 1–10. [Google Scholar]
  78. Bienboire-Frosini, C.; Cozzi, A.; Lafont-Lecuelle, C.; Vervloet, D.; Ronin, C.; Pageat, P. Immunological differences in the global release of the major cat allergen Fel d 1 are influenced by sex and behaviour. Vet. J. 2012, 193, 162–167. [Google Scholar] [CrossRef]
  79. Jalil-Colome, J.; de Andrade, A.D.; Birnbaum, J.; Casanova, D.; Mège, J.L.; Lanteaume, A.; Charpin, D.; Vervloet, D. Sex difference in Fel d 1 allergen production. J. Allergy Clin. Immunol. 1996, 98, 165–168. [Google Scholar] [CrossRef]
  80. Ramadour, M.; Birnbaum, J.; Magalon, C.; Lanteaume, A.; Charpin, D.; Vervloet, D. Cat sex differences in major allergen production (Fel d 1). J. Allergy Clin. Immunol. 1998, 101, 282–284. [Google Scholar] [CrossRef]
  81. Bastien, B.C.; Gardner, C.; Satyaraj, E. Influence of time and phenotype on salivary Fel d1 in domestic shorthair cats. J. Feline Med. Surg. 2019, 21, 867–874. [Google Scholar] [CrossRef]
  82. Zielonka, T.M.; Charpin, D.; Berbis, P.; Luciani, P.; Casanova, D.; Vervloet, D. Effects of castration and testosterone on Fel dI production by sebaceous glands of male cats: I—Immunological assessment. Clin. Exp. Allergy 1994, 24, 1169–1173. [Google Scholar] [CrossRef]
  83. Reperant, L.A.; MacKenzie, J.; Osterhaus, A. Periodic global One Health threats update. One Health 2016, 2, 1–7. [Google Scholar] [CrossRef] [PubMed]
  84. Kumar, R.S.; Tomar, R.; Kumar, P.R.; Nath, S.; Murugan, G.; Ramesh, S. Comparioson of different working equine communities: Their welfare and socio-economic status in Gwalior, India. In Proceedings of the 6th International Colloquium on Working Equids, India Habitat Centre, New Delhi, India, 29 November–2 December 2010; pp. 96–99. [Google Scholar]
  85. Day, M.J. One health: The importance of companion animal vector-borne diseases. Parasites Vectors 2011, 4, 49. [Google Scholar] [CrossRef]
  86. Khurana, S.K.; Dhama, K.; Prasad, M.; Karthik, K.; Tiwari, R. Zoonotic Pathogens Transmitted from Equines: Diagnosis and Control. Adv. Anim. Vet. Sci. 2015, 3, 32–53. [Google Scholar] [CrossRef]
  87. Middleton, D.; Pallister, J.; Klein, R.; Feng, Y.R.; Haining, J.; Arkinstall, R.; Frazer, L.; Huang, J.A.; Edwards, N.; Wareing, M.; et al. Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health. Emerg. Infect. Dis. 2014, 20, 372–379. [Google Scholar] [CrossRef] [PubMed]
  88. Kooijman, L.J.; James, K.; Mapes, S.M.; Theelen, M.J.; Pusterla, N. Seroprevalence and risk factors for infection with equine coronavirus in healthy horses in the USA. Vet. J. 2017, 220, 91–94. [Google Scholar] [CrossRef] [PubMed]
  89. Piva, E.; Liverani, V.; Accorsi, P.A.; Sarli, G.; Gandini, G. Welfare in a shelter dog rehomed with Alzheimer patients. J. Vet. Behav. 2008, 3, 87–94. [Google Scholar] [CrossRef]
  90. Le Roux, M.C.; Kemp, R. Effect of a companion dog on depression and anxiety levels of elderly residents in a long-term care facility. Psychogeriatrics 2009, 9, 23–26. [Google Scholar] [CrossRef]
  91. De Rose, P.; Cannas, E.; Cantiello, P.R. Donkey-assisted rehabilitation program for children: A pilot study. Ann. Ist. Super. Sanita 2011, 47, 391–396. [Google Scholar]
  92. Borioni, N.; Marinaro, P.; Celestini, S.; Del Sole, F.; Magro, R.; Zoppi, D.; Mattei, F.; Armi, V.D.; Mazzarella, F.; Cesario, A.; et al. Effect of equestrian therapy and onotherapy in physical and psycho-social performances of adults with intellectual disability: A preliminary study of evaluation tools based on the ICF classification. Disabil. Rehabil. 2012, 34, 279–287. [Google Scholar] [CrossRef]
  93. Momozawa, Y.; Kusunose, R.; Kikusui, T.; Takeuchi, Y.; Mori, Y. Assessment of equine temperament questionnaire by comparing factor structure between two separate surveys. Appl. Anim. Behav. Sci. 2005, 92, 77–84. [Google Scholar] [CrossRef]
  94. Gonzalez-De Cara, C.A.; Perez-Ecijaa, A.; Aguilera-Aguilera, R.; Rodero-Serrano, E.; Mendoza, F.J. Temperament test for donkeys to be used in assisted therapy. Appl. Anim. Behav. Sci. 2017, 186, 64–71. [Google Scholar] [CrossRef]
  95. McLean, A.K.; Navas González, F.J.; Canisso, I.F. Donkey and Mule Behavior. Vet. Clin. N. Am. Equine Pract. 2019, 35, 575–588. [Google Scholar] [CrossRef] [PubMed]
  96. American Veterinary Medical Association. Animal-Assisted interventions: Definitions. Available online: https://www.avma.org/resources-tools/avma-policies/animal-assisted-interventions-definitions (accessed on 9 February 2023).
  97. d’Angelo, D.; Chirico, A.; Sacchettino, L.; Manunta, F.; Martucci, M.; Cestaro, A.; Avallone, L.; Giordano, A.; Ciani, F. Human-Dog Relationship during the First COVID-19 Lockdown in Italy. Animals 2021, 11, 2335. [Google Scholar] [CrossRef] [PubMed]
  98. Animal Assisted Interventions (AAI). Standards of Practice, Winkle, Dickson & Simpson. 2019. Available online: https://aai-int.org (accessed on 9 February 2023).
  99. Vines, G. The secret power of pets. Nursing 1993, 6, 30–34. [Google Scholar]
  100. Walden, M.; Lovenstein, A.; Randag, A.; Pye, S.; Shannon, B.; Pipkin, E.; Ramick, A.; Helmick, K.; Strickland, M. Methodological Challenges Encountered in a Study of the Impact of Animal-assisted Intervention in Pediatric Heart Transplant Patients. J. Pediatr. Nurs. 2020, 53, 67–73. [Google Scholar] [CrossRef]
  101. Friedman, E.; Krause-Parello, C.A. Companion animals and human health: Benefits, challenges, and the road ahead for human-animal interaction. Rev. Sci. Tech. 2018, 37, 71–82. [Google Scholar] [CrossRef]
  102. American Animal Hospital Association. AAHA Working, Assistance, and Therapy Dog Guidelines. 2021. Available online: https://www.aaha.org/aaha-guidelines/2021-aaha-working-assistance-and-therapy-dog-guidelines/home/ (accessed on 9 February 2023).
  103. American Veterinary Medical Association. Animal-Assisted Intervention: Guidelines. Available online: https://www.avma.org/resources-tools/animal-health-and-welfare/service-emotional-support-and-therapy-animals/animal-assisted-interventions-guidelines (accessed on 9 February 2023).
  104. IAHAIO White Paper 2014, Updated for 2018. The IAHAIO Definitions for Animal Assisted Intervention and Guidelines for Wellness of Animals Involved in AAI. 2018. Available online: http://iahaio.org/wp/wpcontent/uploads/2018/04/iahaio_wp_updated-2018-final.pdf (accessed on 10 December 2018).
  105. Zinsstag, J.; Schelling, E.; Toews, D.W.; Tanner, M. From “one medicine” to “one health” and systemic approaches to health and well-being. Prev. Vet. Med. 2011, 101, 148–156. [Google Scholar] [CrossRef]
  106. Hinchlie, S. More than one world, more than one health: Re-configuring interspecies health. Soc. Sci. Med. 2015, 129, 28–35. [Google Scholar] [CrossRef]
  107. Takashima, G.K.; Day, M.J. Setting the One Health Agenda and the Human–Companion Animal Bond. Int. J. Environ. Res. Public Health 2014, 11, 11110–11120. [Google Scholar] [CrossRef]
  108. Beetz, A.M. Theories and Possible Processes of Action in Animal Assisted Interventions. Appl. Dev. Sci. 2017, 21, 139–149. [Google Scholar] [CrossRef]
  109. Beck, L.; Madresh, E.A. Romantic Partners and Four-Legged Friends: An Extension of Attachment Theory to Relationships with Pets. Anthrozoös 2015, 21, 43–56. [Google Scholar] [CrossRef]
  110. Tóth, L.; Gácsi, M.; Topál, J.; Miklósi, A. Playing styles and possible causative factors in dogs’ behavior when playing with humans. Appl. Anim. Behav. Sci. 2008, 114, 473–484. [Google Scholar] [CrossRef]
  111. Dimitrijevi’c, I. Animal-Assisted Therapy—A New Trend in The Treatment of Children and Adults. Psychiatr. Danub. 2009, 21, 236–241. [Google Scholar]
  112. Muñoz Lasa, S.; Máximo Bocanegra, N.; Valero Alcaide, R.; Atín Arratibel, M.A.; Varela Donoso, E.; Ferriero, G. Intervenciones asistidas por animales en neurorrehabilitación: Una revisión de la literatura más reciente. Neurología 2015, 30, 1–7. [Google Scholar] [CrossRef]
  113. Hediger, K.; Thommen, S.; Wagner, C.; Gaab, J.; Hund-Georgiadis, M. Effects of animal-assisted therapy on social behaviour in patients with acquired brain injury: A randomised controlled trial. Sci. Rep. 2019, 9, 5831. [Google Scholar] [CrossRef]
  114. Machová, K.; Procházková, R.; Eretová, P.; Svobodová, I.; Kotík, I. Effect of Animal-Assisted Therapy on Patients in the Department of Long-Term Care: A Pilot Study. Int. J. Environ. Res. Public Health 2019, 16, 1362. [Google Scholar] [CrossRef]
  115. Machová, K.; Součková, M.; Procházková, R.; Vaníčková, Z.; Mezian, K. Canine-Assisted Therapy Improves Well-Being in Nurses. Int. J. Environ. Res. Public Health 2019, 16, 3670. [Google Scholar] [CrossRef]
  116. Meers, L.L.; Contalbrigo, L.; Samuels, W.E.; Quarte-Gan, C.; Berckmans, D.; Laufer, S.J.; Stevens, V.A.; Walsh, E.A.; Normando, S. Canine-Assisted Interventions and the Relevance of Welfare Assessments for Human Health, and Transmission of Zoonosis: A Literature Review. Front. Vet. Sci. 2022, 9, 899889. [Google Scholar] [CrossRef]
Table 1. Search string used in PubMed, Web of Science, SCOPUS, and Google Scholar.
Table 1. Search string used in PubMed, Web of Science, SCOPUS, and Google Scholar.
(1) “animal-assisted therapy” OR “animal assisted interventions” AND “zoonosis”
(2)“animal-assisted interventions” OR “animal-assisted therapy” AND “dog” AND “zoonosis”
(3) “animal-assisted interventions” OR “animal assisted therapy” AND cat AND “zoonosis”
(4) “animal-assisted interventions” OR “animal-assisted therapy” AND “rabbit” AND “zoonosis”
(5) “animal-assisted interventions” OR “animal-assisted therapy” AND “equine” AND “zoonosis”
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Liguori, G.; Costagliola, A.; Lombardi, R.; Paciello, O.; Giordano, A. Human-Animal Interaction in Animal-Assisted Interventions (AAI)s: Zoonosis Risks, Benefits, and Future Directions—A One Health Approach. Animals 2023, 13, 1592. https://doi.org/10.3390/ani13101592

AMA Style

Liguori G, Costagliola A, Lombardi R, Paciello O, Giordano A. Human-Animal Interaction in Animal-Assisted Interventions (AAI)s: Zoonosis Risks, Benefits, and Future Directions—A One Health Approach. Animals. 2023; 13(10):1592. https://doi.org/10.3390/ani13101592

Chicago/Turabian Style

Liguori, Giovanna, Anna Costagliola, Renato Lombardi, Orlando Paciello, and Antonio Giordano. 2023. "Human-Animal Interaction in Animal-Assisted Interventions (AAI)s: Zoonosis Risks, Benefits, and Future Directions—A One Health Approach" Animals 13, no. 10: 1592. https://doi.org/10.3390/ani13101592

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop